Chen Yong-Bin, Chen Ren-Nian, Li Yu-Lan
Internal Medicine Department, Nanning Manicipal Seventh People's Hospital, Nanning 530012, Guangxi Province, China.
Zhongguo Zhen Jiu. 2012 May;32(5):390-4.
To observe the therapeutic effect of type II early diabetic nephropathies intervened by acupoint thread embedding for strengthening spleen and benefiting kidney.
Sixty cases of type II early diabetic nephropathies were randomly divided into an acupoint thread embedding group and a routine therapy group, 30 cases in each group. In routine therapy group, western medicine routine therapy was applied to control blood sugar, blood pressure and blood lipid. In acupoint thread embedding group, besides the western medicine routine therapy, thread embedding intervention was given at Pishu (BL 20), Zusanli (ST 36), Shenshu (BL 23) and Yishu (Extra) on both sides as main acupints, and the treatment course was 3 months. Urinary micro-albumin excretion (UAER), total score of TCM syndrome and monitor control indices (blood sugar, blood pressure, blood lipid, urea nitrogen and serum creatinine) in both groups were observed before and after treatment, and the therapeutic effects in both groups were compared.
After treatment, the indices of UAER and total score of TCM syndrome were all reduced (P < 0.001, P < 0.01); the reduction in acupoint thread embedding group was more obvious (P < 0.01, P < 0.05); the total effective rate in acupoint thread embedding group was 76.7% (23/30), superior to that of 63.3% (19/30) in routine therapy group (P < 0.05). The blood sugar, blood pressure and blood lipid in both groups were remarkably improved (all P < 0.001) after treatment; the urea nitrogen and creatinine had no notable variation.
Acupoint thread embedding combined with western medicine routine therapy can not only reduce the urinary micro-albumin excretion of type II early diabetic nephropathies, but also improve the Chinese medicine symptoms and the therapeutic effect is superior to that of simple western medicine routine therapy.
观察穴位埋线健脾益肾法干预Ⅱ型早期糖尿病肾病的疗效。
将60例Ⅱ型早期糖尿病肾病患者随机分为穴位埋线组和常规治疗组,每组30例。常规治疗组采用西药常规治疗控制血糖、血压和血脂。穴位埋线组在西药常规治疗基础上,选取双侧脾俞(BL 20)、足三里(ST 36)、肾俞(BL 23)和胰俞(Extra)为主穴进行埋线干预,疗程为3个月。观察两组治疗前后尿微量白蛋白排泄率(UAER)、中医证候总积分及监测控制指标(血糖、血压、血脂、尿素氮和血清肌酐),并比较两组疗效。
治疗后,两组UAER及中医证候总积分均降低(P < 0.001,P < 0.01);穴位埋线组降低更明显(P < 0.01,P < 0.05);穴位埋线组总有效率为76.7%(23/30),优于常规治疗组的63.3%(19/30)(P < 0.05)。两组治疗后血糖、血压和血脂均显著改善(均P < 0.001);尿素氮和肌酐无明显变化。
穴位埋线联合西药常规治疗不仅能降低Ⅱ型早期糖尿病肾病患者的尿微量白蛋白排泄率,还能改善中医症状,疗效优于单纯西药常规治疗。